A carregar...
Negative trials in ovarian cancer: is there such a thing as too much optimism?
Recently, two clinical trials of novel agents in metastatic ovarian cancer were published: a phase 3 study of nintedanib and a phase 2 study of volasertib. There seemed to be discordance between the results and conclusions in the publication of both these trials. Despite not very optimistic results,...
Na minha lista:
| Publicado no: | Ecancermedicalscience |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cancer Intelligence
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990052/ https://ncbi.nlm.nih.gov/pubmed/27594913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2016.ed58 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|